A carregar...
Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
Febuxostat is a nonpurine xanthine oxidase (XO) inhibitor, which recently received marketing approval. However, information regarding the experience with this agent among advanced chronic kidney disease (CKD) patients is limited. In the current study, we investigated the effects of oral febuxostat i...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Libertas Academica
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4134003/ https://ncbi.nlm.nih.gov/pubmed/25210423 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/DTI.S16524 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|